Back to search

Behavioural effects of the newer antiepileptic drugs: an update

Data up to Jan 2025

Published2004
Citations81
References64

Total Citations Per Year

Abstract

References (64)

A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression

1999 • 1,056 citations

Severe persistent visual field constriction associated with vigabatrin

1997 • 453 citations

Gabapentin in bipolar disorder: a placebo‐controlled trial of adjunctive therapy1

2000 • 318 citations

Topiramate and Psychiatric Adverse Events in Patients with Epilepsy

2003 • 248 citations

Randomised, Placebo‐Controlled Study of Vigabatrin as First‐Line Treatment of Infantile Spasms

1999 • 231 citations

Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients

2000 • 219 citations

Review of the Use of Topiramate for Treatment of Bipolar Disorders

2002 • 217 citations

Use of topiramate, a new anti-epileptic as a mood stabilizer

1998 • 199 citations

Oxcarbazepine in Affective and Schizoaffective Disorders

2001 • 199 citations

A systematic review of the safety profile of levetiracetam: a new antiepileptic drug

2001 • 189 citations

Vigabatrin and psychosis.

1991 • 182 citations

A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials

2003 • 178 citations

Topiramate versus Bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single‐blind study

2002 • 170 citations

Levetiracetam Psychosis in Children with Epilepsy

2001 • 156 citations

Carbamazepine Toxicity with Lamotrigine: Pharmacokinetic or Pharmacodynamic Interaction?

1998 • 156 citations

Safety Profile of Levetiracetam

2001 • 132 citations

Gabapentin Toxicity in Children Manifesting as Behavioral Changes

1995 • 126 citations

Psychiatric symptoms after therapy with new antiepileptic drugs: Psychopathological and seizure related variables

2000 • 126 citations

Tiagabine: The Safety Landscape

1995 • 122 citations

Tiagabine

1998 • 117 citations

Psychiatric adverse events during vigabatrin therapy

1999 • 112 citations

Aggressive Behaviour in Intellectually Challenged Patients with Epilepsy Treated with Lamotrigine

1998 • 106 citations

Effects of Mianserin on Negative Symptoms in Schizophrenia

1990 • 106 citations

Tiagabine-induced absence status in idiopathic generalized epilepsy

1999 • 105 citations

Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders

2002 • 100 citations

Acute psychotic symptoms induced by topiramate

1999 • 99 citations

The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania

1994 • 98 citations

Behavioural Effects of the New Anticonvulsants

2001 • 97 citations

Childhood epilepsy in relation to mental handicap and behavioural disorders

2002 • 94 citations

Efficacy of gabapentin therapy in children with refractory partial seizures

1996 • 94 citations

Tiagabine Appears Not to Be Efficacious in the Treatment of Acute Mania

1999 • 93 citations

Tiagabine

1998 • 92 citations

Tiagabine and non-convulsive status epilepticus

1996 • 86 citations

Psychotic and severe behavioural reactions with vigabatrin: a review

2009 • 83 citations

Nonconvulsive Status Epilepticus in Two Patients Receiving Tiagabine Treatment

1998 • 81 citations

A Pilot Study of Topiramate as Monotherapy in the Treatment of Acute Mania

2001 • 75 citations

An audit of topiramate use in a general neurology clinic

1998 • 75 citations

Vigabatrin and behaviour disorders: a retrospective survey

1996 • 74 citations

Psychotic episodes during Zonisamide treatment

2000 • 73 citations

Neuropsychological effects of tiagabine, a potential new antiepileptic drug

1994 • 73 citations

Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic

1999 • 72 citations

Felbamate in Epilepsy Therapy

1999 • 68 citations

Cognitive and Behavioral Effects of Epilepsy Treatment

2001 • 59 citations

Lamotrigine in the treatment of bipolar depression

1999 • 58 citations

Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs

1996 • 55 citations

Felbamate monotherapy has stimulant-like effects in patients with epilepsy

1996 • 54 citations

Felbamate Monotherapy: Implications for Antiepileptic Drug Development

1995 • 44 citations

Anticonvulsant-Induced Psychiatric Disorders

1996 • 41 citations

Long‐Term Safety of Tiagabine

2001 • 39 citations

Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability.

1998 • 37 citations

Acute psychological disorders in patients with epilepsy: a nation-wide study

1996 • 35 citations

Vigabatrin and behaviour disturbances

1990 • 34 citations

Zonisamide and psychosis

1997 • 33 citations

Cognitive and behavioural assessments in clinical trials: what type of measure?

2001 • 31 citations

Treatment of acute mania with topiramate in hospitalized patients

2002 • 29 citations

Occurrence of Psychosis in Patients with Epilepsy Randomized to Tiagabine or Placebo Treatment

2002 • 29 citations

The Use of Topiramate in Mood Stabilization

2002 • 21 citations

Felbamate as Add-On Therapy

1996 • 20 citations

Vigabatrin in Childhood Epilepsy: Comparable Efficacy for Generalized and Partial Seizures

1996 • 17 citations

Confusion and dysphoria with low‐dose topiramate in a patient with bipolar disorder

2001 • 16 citations

Secondary Mania Associated With the Use of Felbamate

1995 • 8 citations

Topiramat - ein wirksames neues Antiepileptikum

1997 • 4 citations

Oxcarbazepine in Acute Mania

1985 • 3 citations

Topiramat – ein wirksames neues Antiepileptikum Eine offene prospektive Studie

1997 • 2 citations

Cited By (0)

Loading...